Cosmo First FY26: A ₹1,140 Crore Capex Binge Meets a Sharp Margin Reset
At a Glance
An aggressive capital expenditure strategy frequently functions as a double-edged sword for cyclical businesses, promising enhanced capacity while simultaneously heightening financial exposure during sudden industry downturns. Cosmo First Limited’s newly published full-year financial report for the period ending March 31, 2026, illustrates this structural tension. The headline numbers display a robust operational recovery on the top line, with full-year revenue scaling 25.69% to hit an all-time high of ₹3,638.72 crore, driven by a 41% surge in sales volumes following recent capacity additions.
Behind this volume growth, a structural divergence in earnings quality has emerged. While full-year EBITDA climbed 32% to ₹479 crore, net profit growth remained constrained at ₹155.98 crore. This divergence is the mathematical residue of a massive ₹1,140 crore capital expansion cycle that has driven annual depreciation up to ₹137.11 crore and escalated finance costs to ₹141 crore. Furthermore, a volatile operating landscape—marked by core Bially Oriented Polypropylene (BOPP) film margin compression to ₹13/kg in the third quarter, a full year of US anti-dumping duties, and a series of one-off operational shocks—has tested the resilience of the bottom line.
The underlying capital efficiency metrics underscore this imbalance. Return on Capital Employed (ROCE) stood at 11% and Return on Equity (ROE) finished at 10.5%, indicating that returns have yet to outpace the company’s cost of capital. Management has formally signaled a shift away from asset accumulation toward cash extraction, emphasizing that the aggressive investment phase is over. Whether the company can efficiently translate its expanded asset base into high-margin cash flows before market conditions shift remains the primary variable for investors.
Introduction
Cosmo First Limited, formerly known as Cosmo Films, has occupied a central position in the flexible packaging landscape since its inception in 1981. The company operates as a major producer of specialty films utilized across packaging, lamination, and labeling applications globally. Over the last three fiscal years, the business has engaged in an aggressive asset transformation, pivoting from its legacy standing as a pure-play packaging manufacturer into a diversified entity spanning chemical processing, rigid plastics, and direct-to-consumer digital ecosystems.
This corporate evolution has been financed by considerable capital additions. Over the past 36 months, the balance sheet has absorbed more than ₹1,140 crore of strategic capex. This capital has funded the commissioning of the world’s largest core BOPP line, a specialized Cast Polypropylene (CPP) line, an advanced Biaxially Oriented Polyethylene Terephthalate (BOPET) facility, and a series of high-barrier coating installations. With the finalization of these production lines in early FY26, the company’s aggregate production capacity has expanded significantly, shifting management’s mandate from construction to operational execution.
Business Model: WTF Do They Even Do?
Cosmo First operates a corporate structure that resembles a classic industrial manufacturer attempting a modern consumer-tech makeover. At its core, the company functions as a B2B plastics business. It converts polypropylene resins into thin sheets used to wrap everything from potato chips to high-end cosmetic labels, selling its output to consumer giants like Pepsi, Coca-Cola, Cadbury, and Hindustan Unilever. The company maintains global market leadership in thermal lamination films and acts as the largest exporter of flexible films out of India, shipping half its production to over 80 countries.
Corporate Architecture: Flagship Films (Cosmo Films): Packaging, Labeling, and Lamination Specialty Chemicals: Coatings, Masterbatches, and Adhesives Rigid Packaging (Cosmo Plastech): Injection-molded FMCG containers Consumer Vertical (Cosmo Consumer): Automotive Window & Paint Protection Films Pet Care (Zigly): Digital ecosystem and retail veterinary hubs
The business model is undergoing a deliberate structural shift. Recognizing that core commodity plastic sheets are vulnerable to raw material volatility and cyclical pricing wars, the company has built multiple non-film segments. It now runs Cosmo Specialty Chemicals, an internal R&D engine producing advanced masterbatches and adhesives; Cosmo Plastech, which manufactures injection-molded rigid containers for FMCG brands; Cosmo Consumer, a brand selling high-margin automotive window shield and paint protection films ; and Zigly, an omni-channel pet care ecosystem complete with grooming apps, private-label pet foods, and brick-and-mortar veterinary hospitals.
Financials Overview
Figures are consolidated, in ₹ crore.
Quarterly Performance Trend
Metric
Q4 FY26
YoY Change
QoQ Change
Sales
₹1,020.68
+36.85%
+13.54%
Operating Profit
₹120.57
+173.28%
+77.26%
Net Profit
₹36.91
+139.99%
+25.12%
Reported EPS
₹14.06
+140.27%
+25.09%
Note: Table data reflects direct Screener extraction and recalculated metrics. YoY matches Q4 FY26 vs Q4 FY25; QoQ matches Q4 FY26 vs Q3 FY26.
The fourth quarter of FY26 delivered a strong top-line performance, crossing the thousand-crore milestone to settle at ₹1,020.68 crore. This revenue expansion represents a 36.85% acceleration year-on-year, driven primarily by the steady commercial ramp-up of the newly commissioned 81,000 TPA core BOPP line. Operating profit rebounded sharply to ₹120.57 crore,
